Table 2.
Green tea consumption and risk of cardiovascular disease from meta-analyses.
Category | Meta | Green tea | Effect | Size | (95% CI) | Studies | Study design | Reference |
---|---|---|---|---|---|---|---|---|
Cardiovascular disease mortality | 3 | Highest vs lowest | RR | 0.67 | (0.46–0.96) | 6 | Cohort | [22] |
≥5 Cups per day | HR |
0.82 0.75 |
(0.75-0.90) men (0.68–0.84) women |
8 | Cohort | [21] | ||
3 Cups per day | RR | 0.81 | (0.68–0.97) | 6 | Prospective | [84] | ||
Stroke | 4 | 3 Cups/day | RR | 0.78 | (0.69–0.88) | 3 | Mixed | [85] |
3 Cups Per day | RR | 0.83 | (0.72–0.96) | 5 | Cohort | [86] | ||
1–3 Cups vs <1 | OR | 0.64 | (0.47–0.86) | 3 | Cohort | [14] | ||
3 Cups per day | RR | 0.66 | (0.46–0.93) | 4 | Prospective | [84] | ||
Coronary artery disease | 1 | Highest | RR | 0.72 | (0.58–0.89) |
2 3 |
Cohort case-control |
[87] |
Coronary heart disease | 1 | 3 Cups per day | RR | 1.02 | (0.92–1.13) | 1 | Prospective | [84] |
Myocardial infarction | 1 | 1–3 Cups vs <1 | OR | 0.81 | (0.67–0.98) | 2 | Cohort | [14] |
Meta: number of meta-analyses; studies: number of original studies included; study design, study design of included original studies.